This month, the editors of AACR’s journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel bispecific immunotherapy, and more.
The post Editors’ Picks, March 2025: Cancer Cell Senescence, Ultraviolet Protection, and More  appeared first on American Association for Cancer Research (AACR).

A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
The post Personalized Vaccines and Beyond: Confronting the Complex Biology of Kidney Cancer appeared first on American Association for Cancer Research (AACR).

After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he started radiation therapy. His oncologist told him he might be eligible for targeted therapy, but he would have to wait four to six weeks for results from tumor tissue testing. The possibility of targeted therapy sounded
The post Cancer Today’s Spring 2025 Issue: How Liquid Biopsies Can Guide Treatment Decisions, Extending Survival in Treatment-resistant Breast Cancer, and More  appeared first on American Association for Cancer Research (AACR).

The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
The post Meet The CheckPoints: A Band of Researchers and Oncologists Giving Cancer Treble  appeared first on American Association for Cancer Research (AACR).

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’

Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk by about 30%. This is because undergoing colonoscopies as recommended (every 10 years beginning at age 45 for those at average risk) gives physicians the chance to detect and remove precancerous growths called adenomas (a type
The post Can a Vaccine Prevent Colorectal Cancer? appeared first on American Association for Cancer Research (AACR).

For one thing, the presence of employees with disabilities improves the culture of the entire organization, making it more collaborative and responsive.

Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
The post Inaugural AACR IO Conference Kicks Off With Celebration of Immune Checkpoints  appeared first on American Association for Cancer Research (AACR).

Limiting exposure to air pollution will have lasting impacts on Colorado communities with the highest exposure.

The key to the for-profit company’s successful partnership with governments, international agencies and humanitarian, nongovernmental organizations is how it handled its patent.